A letter sent Monday by a coalition of business groups to top lawmakers in the state Senate and Assembly urged them to oppose the latest version of an opioid tax in the state budget.

Gov. Andrew Cuomo last month re-introduced a version of the tax as part of his $175 billion spending plan after a similar measure in last year’s budget was struck down by a federal court.

The tax, meant to tackle heroin and opioid addiction, is expected to bring in $100 million.

But the business groups, including NFIB, Unshackle Upstate and the Business Council, argue the tax would only be passed on to consumers and could raise prices as a result.

“Any tax policy that raises costs on the healthcare supply chain of New York State is bad for all aspects of the healthcare system,” they write in the letter.

“But increased healthcare costs would have a significant impact on our state’s economy as a whole, as employers would pay more for their employees’ healthcare coverage and consumers of legitimate opioids would have to spend more out of their own pockets. Not to mention the effect that this tax could have on the bottom line of healthcare facilities, some of the largest job creators in communities throughout the state.”

The full letter can be found here.